Table 1 Demographic and clinical characteristics of the patients

Sex

 Male; n (%)

13 (56.5%)

 Female; n (%)

10 (43.5%)

Age [years]; mean ± SD; median (IQR)

55.5 ± 12.1; 55 (33–78)

BMI [kg/m²]; mean ± SD; median (IQR)

32.5 ± 7.0; 30.7 (22.8–47.8)

Obesity [BMI > 30 kg/m²]; n (%)

13 (56.5%)

Tobacco consumption; n (%)

6 (26.1%)

Alcohol consumption; n (%)

12 (52.2%)

Arterial hypertension; n(%)

10 (43.5%)

Symp-days [days]; mean ± SD; median (IQR)

12.9 ± 3.8; 12 (4–20)

CRP [mg/L]; mean ± SD; median (IQR)

96.9 ± 54.2; 83.9 (6.43–189.0)

Lactate dehydrogenase [U/L]; mean ± SD; median (IQR)

323.4 ± 135.5; 294 (137–768)

HbA1c [%]; n (%); mean ± SD; median (IQR)

20 (86.9%); 6.9 ± 2.0; 6.4 (5.3–12.7)

D-dimer [ng/mL]; mean ± SD; median (IQR)

1508 ± 1706: 778 (255–7331)

INR; mean ± SD; median (IQR)

1.0 ± 0.1; 1.0 (0.8 − 1.2)

ESR [mm/h]; mean ± SD; median (IQR)

62 ± 18; 63 (30–96)

Ferritin [ng/mL]; mean ± SD; median (IQR)

1147.6 ± 895.4; 830 (174–3940)

Fibrinogen [mg/dL]; mean ± SD; median (IQR)

805 ± 1263; 501.8 (363.0-6566.0)

O₂-flow [L/min]; mean ± SD; median (IQR)

2.9 ± 1.4; 3.0 (0.0–5.0)

Saturation of Peripheral Oxygen (SatO₂)[%]; mean ± SD; median (IQR)

95.4 ± 2.0; 95 (91–98)

PO₂ /FiO₂; mean ± SD; median (IQR)

336.2 ± 60.0; 328 (219–528)

Pulmonary CT involvement [%];

 <25%; n (%)

2 (8.7%)

 25-50%; n (%)

14 (60.9%)

 50-75%; n (%)

7 (30.4%)

 >75%; n (%)

0 (0%)

Neurological symptoms

 None

13 (56.5%)

 Mild headache

4 (17.4%)

 Anosmia/hyposmia

5 (21.7%)

 Ageusia/dysgeusia

4 (17.4%)